The Role of Inflammation in the Pathogenesis of Osteoarthritis.
Chow YY, Chin KY. · 2020
Read The Role of Inflammation in the Pathogenesis of Osteoarthritis. by Chow YY, Chin KY. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7072120.txt.
Introduction
Chow and Chin review inflammation in osteoarthritis in Mediators of Inflammation. Osteoarthritis is a chronic, disabling joint disease that mainly strikes the elderly and affects around 250 million people worldwide. It was once framed as simple wear and tear. Evidence now puts inflammation near the centre of how the disease develops.
Mechanical stress on a joint triggers the release of early inflammatory messengers such as interleukin-1 beta. Those signals switch on pathways including NF-kappaB, PI3K/AKT, and MAPK, which generate still more inflammatory molecules. Enzymes such as the collagenase MMP-13 then chew through the joint's extracellular matrix, the scaffolding that gives cartilage its strength. As the matrix fails, the joint's structure and function deteriorate. The review assembles the studies behind each link in that chain, from chemokines that recruit trouble to the enzymes that finish the demolition.
Catalog record
| CREATOR | Chow YY, Chin KY. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Role of Inflammation in the Pathogenesis of Osteoarthritis By Yoke Yue Chow, Kok-Yong Chin Published in: Mediators of Inflammation DOI: 10.1155/2020/8293921 ABSTRACT Abstract A joint is the point of connection between two bones in our body. Inflammation of the joint leads to several diseases, including osteoarthritis, which is the concern of this review. Osteoarthritis is a common chronic debilitating joint disease mainly affecting the elderly. Several studies showed that inflammation triggered by factors like biomechanical stress is involved in the development of osteoarthritis. This stimulates the release of early-stage inflammatory cytokines like interleukin-1 beta (IL-1β), which in turn induces the activation of signaling pathways, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), phosphoinositide 3-kinase/protein kinase B (PI3K/AKT), and mitogen-activated protein kinase (MAPK). These events, in turn, generate more inflammatory molecules. Subsequently, collagenase like matrix metalloproteinases-13 (MMP-13) will degrade the extracellular matrix. As a result, anatomical and physiological functions of the joint are altered. This review is aimed at summarizing the previous studies highlighting the involvement of inflammation in the pathogenesis of osteoarthritis. 1. INTRODUCTION Osteoarthritis or degenerative arthritis is a public health issue in an aging society. It is a chronic musculoskeletal disorder of the movable joints, such as knee and hip joints [1]. Osteoarthritis affects around 250 million people around the world, the majority of which are the elderly [2]. Changes in the joint tissues during aging can contribute to the development of osteoarthritis. For instance, an increase in cells manifesting senescent secretory phenotype leads to enhanced production of cytokines and matrix metalloproteinases (MMPs) in the joint environment [3]. Furthermore, reduced growth factors and the responsiveness of chondrocytes will cause less matrix synthesis and repair [3]. Other than aging, environmental, biomechanical, and biochemical factors can also contribute to the initiation of osteoarthritis. Osteoarthritis affects the entire structures of the joints, including articular cartilage, subchondral bone, meniscus, synovial membrane, and infrapatellar fat pad (IFP). The common structural characteristics of osteoarthritis are cartilage degradation, subchondral bone remodeling, osteophyte formation, and changes in the synovium and joint capsule [4]. Patients with osteoarthritis have typical clinical symptoms, such as severe joint pain, stiffness, and significantly reduced mobility, leading to decreased productivity and quality of life among the patients, as well as increased socioeconomic burden to the patients and the society [5]. As the prevalence of osteoarthritis increases with age, the aging population worldwide makes this disease a nonnegligible issue [6]. Current therapies for osteoarthritis are limited to symptom-relieving drugs and total knee arthroplasty for severe cases. Drugs addressing the underlying biological causes of osteoarthritis are not available in the market currently [7]. The involvement of immune cells in the development and progression of osteoarthritis has been highlighted in recent studies [8]. Inflammatory components, such as cytokines and chemokines, are produced by chondrocytes and synoviocytes in the joints of patients with osteoarthritis. Synovial fibroblasts are also a source of proinflammatory cytokines and matrix-degrading enzymes under osteoarthritis condition [9]. Moreover, IFP has been shown to contain a significant amount of immune cells like macrophage and T cells. As a result, IFP acts as a site of inflammatory mediators in osteoarthritic knee [10]. These inflammatory mediators alter cell signaling pathways, gene expression, and behavior of joint tissue [11]. The changes in cellular signal transduction lead to enhanced activation of the inflammatory pathway. Thus, more inflammatory compounds and enzymes are released. As a result, anatomical and physiological functions of the joint are altered [12]. This review is aimed at summarizing the recent clinical and preclinical studies performed previously to investigate the relationship between joint inflammation and the pathogenesis of osteoarthritis. The mechanism by which inflammation contributes to the pathogenesis of osteoarthritis will also be discussed. 2. LITERATURE SEARCH A literature search on original articles written in English and published between 2014 and 2019 was performed using Scopus and PubMed database with the string: (osteoarthritis OR chondrocytes) AND inflammation. Both preclinical and clinical studies were included in this review. The search showed studies on human, animal, and cell lines investigating the involvement of inflammation in osteoarthritis by determining the differential expressions of genes, inflammatory components, and enzymes. Samples collected in human studies include synovial fluid and articular cartilage, from patients who underwent total knee arthroplasty, as well as blood (Table 1). For animal studies, agents, such as interleukin-1 beta (IL-1β) and monosodium iodoacetate (MIA), were used to induce osteoarthritis in the animal models (Table 2). Samples like articular cartilage and synovial tissue were taken after the treatment period. Agents such as IL-1β and tumor necrosis factor-alpha (TNF-α) were applied on cell lines to trigger inflammation (Table 3). [Table: Molecular changes in humans with osteoarthritis.] [Table: Molecular changes in animal model of osteoarthritis.] [Table: Molecular changes in cellular model of osteoarthritis.] 3. THE ROLE OF IMMUNE CELLS IN OSTEOARTHRITIS Immune cells like activated neutrophils and macrophages can secrete cytokines, such as IL-6 and IL-1β, which amplify the inflammatory process in osteoarthritis [13]. Increased infiltration of leukocytes (macrophages, T-lymphocytes, B-lymphocytes, and neutrophils) in the synovium, particularly within the subintimal layer, is a characteristic of osteoarthritis [14]. Shan et al. reported elevated PD1+CXCR5+CD4+ T cells, ICOS+CXCR5+CD4+ T cells, and IL 21+CXCR5+CD4+ T cells in peripheral blood of patients with osteoarthritis [15]. CD4+ T cell is the T helper cell (Th cell) which may induce inflammation in the early stage of osteoarthritis. C-X-C chemokine receptor type 5 (CXCR5), inducible costimulator (ICOS), and programmed cell death 1 (PD-1) are known to be expressed by the Th cell [15]. Lymphocyte activation gene-3 (LAG-3+) regulatory T cells (Treg cells) have also been shown to increase in osteoarthritis [16]. Treg cells act as an immunoregulator in many inflammatory diseases [17]. It regulates the secretion of anti-inflammatory cytokines and expression of cytokine receptors [17]. Evidence showed that the response of Treg cells decreased in osteoarthritis in concurrent with an increase of LAG-3 expression in osteoarthritis. It has been postulated that LAG-3 molecules can reduce Treg function and boost inflammation [16]. CD3+ T cells are revealed as the predominant immune cells in IFP of dogs with canine cruciate ligament disease, which is associated with osteoarthritis, followed by CD14+ macrophages [18]. Both cell types can produce various cytokines such as IL-1β and IL-6 when activated. Immune cells and inflammatory mediators secreted in IFP will interact with other joint tissues, which can promote the pathological process of osteoarthritis [10]. At the same time, cartilage and the synovium are also shown to modulate the IFP. IL-1β stimulates increased proinflammatory cytokine secretion by IFP [19], suggesting that a cross-talk happens between IFP and joint tissues. 4. THE ROLE OF CYTOKINES IN OSTEOARTHRITIS Cytokines secreted by the immune cells are the main players of any inflammatory conditions, including osteoarthritis [7]. Proinflammatory cytokines, such as IL-1β and TNF-α, are among the mediators secreted in early osteoarthritis [20–23]. IL-1β and TNF-α drive the inflammatory cascade independently or in collaboration with other cytokines [24]. They are produced by activated chondrocytes, synoviocytes, and mononuclear cells [25]. TNF-α and IL-1β have been used to trigger inflammation in chondrocyte and synoviocyte culture. Upon stimulation, the cells release IL-6 [26], IL-8 [27], IL-10 [28], IL-1β [29], and TNF-α [28]. Similar cytokine profile was increased in animal models of osteoarthritis [18, 30–34]. IL-1β is involved in a series